Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
S&P Pharmaceuticals SPDR
(NY:
XPH
)
49.26
USD
+0.94 (+1.95%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about S&P Pharmaceuticals SPDR
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
Here are three pharmaceutical ETFs have dropped to support, which means they may be about to rebound.
Tags
Pharma/Biotech
ETFs
Market News
From
Blogs - TalkMarkets
3 Pharmaceutical ETFs That Could Be Due For A Rebound
April 15, 2021
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration ...
Tags
XPH
PILL
Long Ideas
From
Benzinga
Sum Up The Parts: XPH Could Be Worth $67
March 25, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Beyond COVID, Regeneron Is Betting Big on Oncology
March 09, 2021
Future growth will depend on its new checkpoint inhibitor wrangling market share away from Merck's Keytruda.
Tags
Market News
XPH
RHHBY
From
Motley Fool
The Math Shows XPH Can Go To $68
February 25, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Implied XPH Analyst Target Price: $68
February 17, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Large Cap Biopharma Stalled With Move to Small Caps and Reflation Trade
February 15, 2021
Defensive large-cap biopharma stocks stalled as traders moved out on the risk curve seeking faster gains.
Tags
Stocks / Equities
ETFs
Healthcare
From
Blogs - TalkMarkets
Pharma ETFs in Focus Post Q4 Earnings
February 05, 2021
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail.
Tags
ETFs
Healthcare
From
Blogs - TalkMarkets
Sum Up The Pieces: XPH Could Be Worth $67
January 22, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Analysts Anticipate XPH Will Reach $67
January 14, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Analysts See 28% Upside For The Holdings of XPH
December 31, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
How The Pieces Add Up: XPH Headed For $65
December 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
November 15, 2020
The pharmaceutical industry has delivered aC$1 billion ($761 million) proposal to the Canadian government in an attempt to stave ...
Tags
Market News
pharmaceuticals
Canada
From
Benzinga
Analysts Anticipate XPH To Hit $62
October 27, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
How The Parts Add Up: XPH Targets $60
August 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
A Low-Cost Pharma Fund for Drug Sector Exposure
August 22, 2020
The SPDR S&P Pharmaceuticals ETF (XPH) tracks an equal-weighted index of U.S. pharmaceutical companies. The exchange-traded fund seeks to provide exposure to the pharmaceuticals segment of the S&P...
Tags
Pharma/Biotech
Stocks / Equities
ETFs
From
Blogs - TalkMarkets
2 Forever Pharma Stocks to Buy Now
August 14, 2020
Only one of these stocks has performed well this year, but both are worth buying and holding over the long term.
Tags
NVO
XPH
MRK
From
Motley Fool
Look Under The Hood: XPH Has 29% Upside
July 17, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
3 Reasons to Buy Eli Lilly Stock
July 08, 2020
Eli Lilly has been outperforming — and could continue to outperform — the market.
Tags
Market News
XPH
LLY
From
Motley Fool
Expect Pharma M&A to Rebound After COVID-19 Eases
April 22, 2020
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially...
From
ETFdb
Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases
April 17, 2020
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially...
Tags
PPH
Pharmaceuticals
tactical allocation channel
From
ETF Trends
Pharma ETFs Gain On Healthy Q4 Earnings
February 07, 2020
Strong results led to solid trading in pharma ETFs over the past week. Here they are in detail.
Tags
ETFs
From
Blogs - TalkMarkets
Could A More Significant Volatility Breakout Be Underway?
January 27, 2020
In a market that has been steadily climbing despite impeachment proceedings against President Trump, a roller-coaster ride due to tariffs and a trade war with China, and generalized global uncertainty,...
Tags
GLD / SPDR Gold Shares ETF
XPH
Powershares QQQ
From
ETF Trends
A Look at the S&P Sectors from 2019
January 08, 2020
By Canterbury Investment Management Market State 1 (Bullish) – The S&P 500 continues its run in Market State 1, now at 14 consecutive days. Many equity assets experienced a nice little move to end...
Tags
IHI
ETF Strategist Channel
XPH
From
ETF Trends
How The Parts Add Up: XPH Headed For $54
December 30, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
XPH's Holdings Could Mean 17% Gain Potential
December 20, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Best & Worst Monthly Performers: December 18 Edition
December 18, 2019
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as...
From
ETFdb
Is Coiled Volatility Suggesting Big Stock Move?
November 19, 2019
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite...
From
ETFdb
Markets Bounce Back & Close Week Near Record Highs
November 12, 2019
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week....
From
ETFdb
Could Coiled Volatility Suggest A Bigger Stock Move Is Coming?
November 11, 2019
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite...
Tags
Relative Value Channel
GLDM
LQD
From
ETF Trends
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.